VYNE Therapeutics (VYNE) PT Lowered to $4 at Cowen
Tweet Send to a Friend
Cowen analyst Ken Cacciatore lowered the price target on VYNE Therapeutics (NASDAQ: VYNE) to $4.00 (from $10.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
